Quaker Chemical Corporation reported flat underlying volumes in the fourth quarter of 2025, with December performance constrained by adverse weather conditions and operational disruptions that suppressed volumes by approximately 1%. The company attributed the muted results to challenging market conditions, though management expressed confidence in the trajectory ahead.
Looking forward to 2027, Quaker Chemical projects mid-single digit revenue and volume expansion, underpinned by anticipated organic share gains ranging from 2% to 4% and contributions from its Dipsol acquisition. The company targets gross margin recovery to 36-37% and aims to achieve an 18% EBITDA margin through manufacturing consolidation initiatives and operational cost reductions. These margin targets reflect management's commitment to operational efficiency and cost discipline across the organization.
Geographic performance remains uneven, with the Americas and EMEA regions continuing to experience sluggish demand with limited signs of broad-based recovery. In contrast, Asia Pacific operations have demonstrated stronger momentum, delivering consistent share gains and serving as a relative bright spot in the company's portfolio. The divergent regional performance underscores the importance of Quaker Chemical's geographic diversification strategy as it navigates varying macroeconomic conditions across global markets.